These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21179434)

  • 21. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
    PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania.
    Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK
    Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Impact of Oral Azithromycin Taken by Gambian Women During Labor on Prevalence and Antibiotic Susceptibility of Streptococcus pneumoniae and Staphylococcus aureus in Their Infants: Follow-up of a Randomized Clinical Trial.
    Bojang A; Camara B; Jagne Cox I; Oluwalana C; Lette K; Usuf E; Bottomley C; Howden BP; D'Alessandro U; Roca A
    Clin Infect Dis; 2018 Sep; 67(8):1191-1197. PubMed ID: 29608659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of azithromycin as the empiric therapy in children with community-acquired pneumonia who were isolated macrolide resistant Streptococcus pneumoniae from nasopharynx].
    Nariai A; Okitsu N; Inoue M
    Kansenshogaku Zasshi; 2004 Jun; 78(6):490-5. PubMed ID: 15287476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains.
    van Gils EJ; Veenhoven RH; Hak E; Rodenburg GD; Keijzers WC; Bogaert D; Trzcinski K; Bruin JP; van Alphen L; van der Ende A; Sanders EA
    JAMA; 2010 Sep; 304(10):1099-106. PubMed ID: 20823436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasopharyngeal Pneumococcal Serotypes Before and After Mass Azithromycin Distributions for Trachoma.
    Keenan JD; Sahlu I; McGee L; Cevallos V; Vidal JE; Chochua S; Hawkins P; Gebre T; Tadesse Z; Emerson PM; Gaynor BD; Lietman TM; Klugman KP
    J Pediatric Infect Dis Soc; 2016 Jun; 5(2):222-6. PubMed ID: 27199475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasopharyngeal carriage of community-acquired, antibiotic-resistant Streptococcus pneumoniae in a Zambian paediatric population.
    Woolfson A; Huebner R; Wasas A; Chola S; Godfrey-Faussett P; Klugman K
    Bull World Health Organ; 1997; 75(5):453-62. PubMed ID: 9447779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx.
    Gladstone RA; Bojang E; Hart J; Harding-Esch EM; Mabey D; Sillah A; Bailey RL; Burr SE; Roca A; Bentley SD; Holland MJ
    Clin Microbiol Infect; 2021 Jun; 27(6):864-870. PubMed ID: 32750538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae.
    Morita JY; Kahn E; Thompson T; Laclaire L; Beall B; Gherardi G; O'Brien KL; Schwartz B
    Pediatr Infect Dis J; 2000 Jan; 19(1):41-6. PubMed ID: 10643849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review.
    O'Brien KS; Emerson P; Hooper PJ; Reingold AL; Dennis EG; Keenan JD; Lietman TM; Oldenburg CE
    Lancet Infect Dis; 2019 Jan; 19(1):e14-e25. PubMed ID: 30292480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH
    Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumococcal Carriage and Antibiotic Resistance in Children Younger than 5 Years in Nouna District, Burkina Faso.
    Coulibaly B; Sié A; Kiemde D; Dembélé N; Compaore A; Dabo O; Dah C; Ouermi L; Cevallos V; Lebas E; Brogdon JM; Keenan JD; Oldenburg CE
    Am J Trop Med Hyg; 2020 Aug; 103(2):684-688. PubMed ID: 32458778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates.
    Pelton SI; Loughlin AM; Marchant CD
    Pediatr Infect Dis J; 2004 Nov; 23(11):1015-22. PubMed ID: 15545856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of pneumococcal nasopharyngeal cultures for the assessment of nonresponsive acute otitis media in children.
    Eldan M; Leibovitz E; Piglansky L; Raiz S; Press J; Yagupsky P; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2000 Apr; 19(4):298-303. PubMed ID: 10783018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotyping and serotyping of macrolide and multidrug resistant Streptococcus pneumoniae isolated from carrier children.
    Swedan SF; Hayajneh WA; Bshara GN
    Indian J Med Microbiol; 2016; 34(2):159-65. PubMed ID: 27080766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample.
    Finkelstein JA; Huang SS; Daniel J; Rifas-Shiman SL; Kleinman K; Goldmann D; Pelton SI; DeMaria A; Platt R
    Pediatrics; 2003 Oct; 112(4):862-9. PubMed ID: 14523178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.
    Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
    J Infect Dis; 2015 Apr; 211(7):1144-53. PubMed ID: 25355940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of nasopharyngeal antibiotic-resistant pneumococcal carriage in children attending private paediatric practices in Johannesburg.
    Huebner RE; Wasas AD; Klugman KP;
    S Afr Med J; 2000 Nov; 90(11):1116-21. PubMed ID: 11196033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
    Bergman M; Huikko S; Huovinen P; Paakkari P; Seppälä H;
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3646-50. PubMed ID: 16940064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.